AAAAAA
Results:
1-25
|
Results: 25
Authors:
HARRISON CN
HUDSON GV
DEVEREUX S
LINCH DC
Citation: Cn. Harrison et al., OUTCOME OF SECONDARY MYELOID MALIGNANCY IN HODGKINS-DISEASE - THE BNLI EXPERIENCE, European journal of haematology, 61(2), 1998, pp. 109-112
Authors:
LINCH DC
MILLIGAN DW
WINFIELD DA
KELSEY SM
JOHNSON SA
LITTLEWOOD TJ
SMITH GM
HUTCHINSON RM
GOLDSTONE AH
FIELDING AK
HUDSON GV
Citation: Dc. Linch et al., G-CSF AFTER PBSC TRANSPLANTATION, British Journal of Haematology, 101(3), 1998, pp. 595-596
Authors:
HORWICH A
SWERDLOW AJ
BARBER JA
HUDSON GV
GUPTA RK
LINCH D
CUNNINGHAM D
LISTOR TA
Citation: A. Horwich et al., ANALYSIS OF 2ND MALIGNANCY AFTER HODGKINS-DISEASE, British Journal of Cancer, 78, 1998, pp. 9-9
Authors:
HANCOCK BW
AITKEN M
RADSTONE C
HUDSON GV
Citation: Bw. Hancock et al., WHY DONT CANCER-PATIENTS GET ENTERED INTO CLINICAL-TRIALS - EXPERIENCE OF THE SHEFFIELD LYMPHOMA GROUPS COLLABORATION IN BRITISH NATIONAL LYMPHOMA INVESTIGATION STUDIES, BMJ. British medical journal, 314(7073), 1997, pp. 36-37
Authors:
HANCOCK BW
CULLEN MH
HUDSON GV
Citation: Bw. Hancock et al., ALTERNATING CHIVPP PAB1OE IS BETTER THAN PAB1OE ALONE AS INITIAL CHEMOTHERAPY FOR ADVANCED HODGKINS-DISEASE (HD) - FIRST RESULTS OF A BRITISH NATIONAL LYMPHOMA INVESTIGATION (BNLI)/CENTRAL LYMPHOMA GROUP (CLG)STUDY/, European journal of cancer, 33, 1997, pp. 1186-1186
Authors:
LINCH DC
HUDSON BV
ANDERSON L
HUDSON GV
Citation: Dc. Linch et al., IMPACT OF HIGH-DOSE SALVAGE THERAPY (BEAM) ON OVERALL SURVIVAL IN YOUNGER PATIENTS WITH ADVANCED LARGE-CELL LYMPHOMAS ENTERED INTO BNLI TRIALS, Annals of oncology, 8, 1997, pp. 63-65
Authors:
VANDENBERGHE E
DEWOLFPEETERS C
HUDSON GV
HUDSON BV
PITTALUGA S
ANDERSON L
LINCH DC
Citation: E. Vandenberghe et al., THE CLINICAL OUTCOME OF 65 CASES OF MANTLE CELL LYMPHOMA INITIALLY TREATED WITH NON-INTENSIVE THERAPY BY THE BRITISH NATIONAL LYMPHOMA INVESTIGATION GROUP, British Journal of Haematology, 99(4), 1997, pp. 842-847
Authors:
LINCH DC
MILLIGAN DW
WINFIELD DA
KELSEY SM
JOHNSON SA
LITTLEWOOD TJ
SMITH GM
HUTCHINSON RM
GOLDSTONE AH
FIELDING AK
HUDSON GV
Citation: Dc. Linch et al., G-CSF AFTER PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN LYMPHOMA PATIENTS SIGNIFICANTLY ACCELERATED NEUTROPHIL RECOVERY AND SHORTENED TIME IN-HOSPITAL - RESULTS OF A RANDOMIZED BNLI TRIAL, British Journal of Haematology, 99(4), 1997, pp. 933-938
Authors:
DENHAM JW
DENHAM E
DEAR KB
HUDSON GV
Citation: Jw. Denham et al., THE FOLLICULAR NON-HODGKINS-LYMPHOMAS .1. THE POSSIBILITY OF CURE, European journal of cancer, 32A(3), 1996, pp. 470-479
Authors:
DENHAM JW
DENHAM E
DEAR KB
HUDSON GV
Citation: Jw. Denham et al., THE FOLLICULAR NON-HODGKINS-LYMPHOMAS .2. PROGNOSTIC FACTORS - WHAT DO THEY MEAN, European journal of cancer, 32A(3), 1996, pp. 480-490
Authors:
VANDENBERGHE E
DEWOLFPEETERS C
HUDSON GV
HUDSON BV
ANDERSON L
LINCH DC
Citation: E. Vandenberghe et al., OUTCOME OF MANTLE CELL LYMPHOMAS - A STUDY FROM THE BRITISH NATIONAL LYMPHOMA INVESTIGATION GROUP (BNLI), British Journal of Haematology, 93, 1996, pp. 282-282
Authors:
SWERDLOW AJ
JACOBS PA
MARKS A
MAHER EJ
YOUNG T
BARBER JCK
HUDSON GV
Citation: Aj. Swerdlow et al., FERTILITY, REPRODUCTIVE OUTCOMES, AND HEALTH OF OFFSPRING, OF PATIENTS TREATED FOR HODGKINS-DISEASE - AN INVESTIGATION INCLUDING CHROMOSOMEEXAMINATIONS, British Journal of Cancer, 74(2), 1996, pp. 291-296
Authors:
LINCH DC
HUDSON BV
HANCOCK BW
HOSKIN PJ
CUNNINGHAM DC
NEWLAND AC
MILLIGAN DW
STEVENSON PA
WOOD JK
MACLENNAN KA
ANDERSON L
GREGORY WM
HUDSON GV
Citation: Dc. Linch et al., A RANDOMIZED COMPARISON OF A 3RD-GENERATION REGIMEN (PACEBOM) WITH A STANDARD REGIMEN (CHOP) IN PATIENTS WITH HISTOLOGICALLY AGGRESSIVE NON-HODGKINS-LYMPHOMA - A BRITISH NATIONAL LYMPHOMA INVESTIGATION REPORT, British Journal of Cancer, 74(2), 1996, pp. 318-322
Authors:
TURNER S
MAHER EJ
YOUNG T
YOUNG J
HUDSON GV
Citation: S. Turner et al., WHAT ARE THE INFORMATION PRIORITIES FOR CANCER-PATIENTS INVOLVED IN TREATMENT DECISIONS - AN EXPERIENCED SURROGATE STUDY IN HODGKINS-DISEASE, British Journal of Cancer, 73(2), 1996, pp. 222-227
Authors:
HILL ME
MACLENNAN KA
CUNNINGHAM DC
HUDSON BV
BURKE M
CLARKE P
DISTEFANO F
ANDERSON L
HUDSON GV
MASON D
SELBY P
LINCH DC
Citation: Me. Hill et al., PROGNOSTIC-SIGNIFICANCE OF BCL-2 EXPRESSION AND BCL-2 MAJOR BREAKPOINT REGION REARRANGEMENT IN DIFFUSE LARGE-CELL NON-HODGKINS-LYMPHOMA - ABRITISH NATIONAL LYMPHOMA INVESTIGATION STUDY, Blood, 88(3), 1996, pp. 1046-1051
Authors:
PENIKET AJ
HUDSON GV
ANDERSON L
LINCH DC
Citation: Aj. Peniket et al., CHRONIC RELAPSING HODGKINS-DISEASE - AN ANALYSIS OF 167 CASES FROM THE BRITISH NATIONAL LYMPHOMA (BNLI) DATABASE, Blood, 88(10), 1996, pp. 892-892
Authors:
HARRISON CN
HUDSON GV
PERRY A
ANDERSON L
MACMILLAN A
DEVEREUX S
GOLDSTONE AH
LINCH DC
Citation: Cn. Harrison et al., BEAM AND ABMT PBSCT MAY REDUCE THE RISK OF SECONDARY LEUKEMIA IN HODGKINS-DISEASE - A CASE-CONTROL ANALYSIS WITH THE BNLI DATABASE/, Blood, 88(10), 1996, pp. 1036-1036
Authors:
KELSEY SM
NEWLAND AC
HUDSON GV
JELLIFFE AM
Citation: Sm. Kelsey et al., A BRITISH-NATIONAL-LYMPHOMA-INVESTIGATION RANDOMIZED TRIAL OF SINGLE-AGENT CHLORAMBUCIL PLUS RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN LOW-GRADE, LOCALIZED NON-HODGKINS-LYMPHOMA, Medical oncology, 11(1), 1994, pp. 19-25
Authors:
HUDSON BV
HUDSON GV
LINCH DC
ANDERSON L
Citation: Bv. Hudson et al., LATE MORTALITY IN YOUNG BNLI PATIENTS CURED OF HODGKINS-DISEASE, Annals of oncology, 5, 1994, pp. 190000065-190000066
Authors:
HANCOCK BW
HUDSON GV
HUDSON BV
LINCH DC
ANDERSON L
MACLENNAN KA
Citation: Bw. Hancock et al., HYBRID LOPP EVA IS NOT BETTER THAN LOPP ALTERNATING WITH EVAP - A PREMATURELY TERMINATED BRITISH NATIONAL LYMPHOMA INVESTIGATION RANDOMIZEDTRIAL, Annals of oncology, 5, 1994, pp. 190000117-190000120
Authors:
BOTES NP
WILLIAMS MV
BESSELL EM
HUDSON GV
HUDSON BV
Citation: Np. Botes et al., EFFICACY AND TOXICITY OF VINBLASTINE, BLEOMYCIN, AND METHOTREXATE WITH INVOLVED-FIELD RADIOTHERAPY IN CLINICAL STAGE IA AND IIA HODGKINS-DISEASE - A BRITISH NATIONAL LYMPHOMA INVESTIGATION PILOT-STUDY, Journal of clinical oncology, 12(2), 1994, pp. 288-296
Authors:
HUDSON BV
HUDSON GV
MACLENNAN KA
ANDERSON L
LINCH DC
Citation: Bv. Hudson et al., CLINICAL STAGE-1 NON-HODGKINS-LYMPHOMA - LONG-TERM FOLLOW-UP OF PATIENTS TREATED BY THE BRITISH NATIONAL LYMPHOMA INVESTIGATION WITH RADIOTHERAPY ALONE AS INITIAL THERAPY, British Journal of Cancer, 69(6), 1994, pp. 1088-1093
Authors:
CRELLIN AM
HUDSON BV
BENNETT MH
HARLAND S
HUDSON GV
Citation: Am. Crellin et al., NON-HODGKINS-LYMPHOMA OF THE TESTIS, Radiotherapy and oncology, 27(2), 1993, pp. 99-106
Authors:
LINCH DC
WINFIELD D
GOLDSTONE AH
MOIR D
HANCOCK B
MCMILLAN A
CHOPRA R
MILLIGAN D
HUDSON GV
Citation: Dc. Linch et al., DOSE INTENSIFICATION WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN RELAPSED AND RESISTANT HODGKINS-DISEASE - RESULTS OF A BNLI RANDOMIZED TRIAL, Lancet, 341(8852), 1993, pp. 1051-1054
Authors:
SWERDLOW AJ
DOUGLAS AJ
HUDSON GV
HUDSON BV
MACLENNAN KA
Citation: Aj. Swerdlow et al., RISK OF 2ND PRIMARY-CANCER AFTER HODGKINS-DISEASE IN PATIENTS IN THE BRITISH-NATIONAL-LYMPHOMA-INVESTIGATION - RELATIONSHIPS TO HOST FACTORS, HISTOLOGY AND STAGE OF HODGKINS-DISEASE, AND SPLENECTOMY, British Journal of Cancer, 68(5), 1993, pp. 1006-1011
Risultati:
1-25
|